Gentris, a pharmacogenomics services company, will present a webcast on the benefits of DNA “banking” on Wednesday.

The program will be led by Michael Murphy, Gentris’ CEO.

“A well-constructed DNA banking plan can be viewed as an insurance plan for drug developers, allowing them to have a second chance to understand unexpected outcomes” Murphy said.

The webinar will start at 1:30 PM EST.

To pre-register for this event, go to: